Differing Effects of Interleukin-10 on Cutaneous and Pulmonary Francisella tularensis Live Vaccine Strain Infection

ABSTRACT We investigated the role of interleukin-10 (IL-10) in cutaneous and pulmonary infection with Francisella tularensis. We found that after intradermal challenge of mice with the live vaccine strain (LVS) of F. tularensis, splenic IL-10 levels increased rapidly and reached a peak 5 days after infection. However, IL-10 expression after infection was detrimental, since IL-10−/− mice showed increased bacterial clearance and were resistant to an infectious dose (>106 CFU/mouse) that was uniformly lethal for IL-10+/+ mice. Furthermore, IL-10+/+ mice treated with neutralizing anti-IL-10R monoclonal antibody were able to survive lethal cutaneous LVS challenge. The presence of IL-10 appeared to restrain the expression of IL-17, since high levels of splenic IL-17 were observed after intradermal LVS infection only in IL-10−/− mice. Furthermore, treatment with neutralizing anti-IL-17R antibody ablated the enhanced survival observed in IL-10−/− mice. However, neutralization of IL-10 activity in IL-17R−/− mice failed to provide protection. Thus, IL-10 suppresses a protective IL-17 response that is necessary for resistance to cutaneous LVS infection. Surprisingly, however, IL-10−/− mice were significantly more susceptible to pulmonary infection with LVS. Finally, although IL-10 is a critical and novel regulator of immunity to F. tularensis LVS infection, its effects were masked during infection with the highly virulent SchuS4 strain. Taken together, these findings suggest that differentially regulating expression of the IL-10 pathway in various tissues could ultimately have prophylactic and therapeutic benefits for protection against tularemia.

[1]  B. Napier,et al.  Subversion of Host Recognition and Defense Systems by Francisella spp , 2012, Microbiology and Molecular Reviews.

[2]  B. Sahay,et al.  Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia , 2011, Journal of leukocyte biology.

[3]  J. W. Conlan.  Francisella tularensis: a red-blooded pathogen. , 2011, The Journal of infectious diseases.

[4]  K. Elkins,et al.  Immunity to Francisella , 2011, Front. Microbio..

[5]  C. Bosio.  The Subversion of the Immune System by Francisella Tularensis , 2011, Front. Microbio..

[6]  Wangxue Chen,et al.  Molecular Immune Responses to Aerosol Challenge with Francisella tularensis in Mice Inoculated with Live Vaccine Candidates of Varying Efficacy , 2010, PloS one.

[7]  A. Shafferman,et al.  The Involvement of IL-17A in the Murine Response to Sub-Lethal Inhalational Infection with Francisella tularensis , 2010, PloS one.

[8]  G. Bancroft,et al.  Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.

[9]  J. Frelinger,et al.  Lung CD4−CD8− Double-Negative T Cells Are Prominent Producers of IL-17A and IFN-γ during Primary Respiratory Murine Infection with Francisella tularensis Live Vaccine Strain , 2010, The Journal of Immunology.

[10]  D. Metzger,et al.  IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression , 2010, Mucosal Immunology.

[11]  D. Metzger,et al.  Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections , 2010, The Journal of Immunology.

[12]  D. Metzger,et al.  A Detrimental Effect of Interleukin-10 on Protective Pulmonary Humoral Immunity during Primary Influenza A Virus Infection , 2010, Journal of Virology.

[13]  J. Alcorn,et al.  Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. , 2009, Immunity.

[14]  H. Ochs,et al.  IL-10 Deficiency Unleashes an Influenza-Specific Th17 Response and Enhances Survival against High-Dose Challenge1 , 2009, The Journal of Immunology.

[15]  T. Braciale,et al.  Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10 , 2009, Nature Medicine.

[16]  D. Flaherty,et al.  Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.

[17]  Jianfei Yang,et al.  Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells , 2008, European journal of immunology.

[18]  J. Frelinger,et al.  Respiratory Francisella tularensis Live Vaccine Strain Infection Induces Th17 Cells and Prostaglandin E2, Which Inhibits Generation of Gamma Interferon-Positive T Cells , 2008, Infection and Immunity.

[19]  A. Sjöstedt.  Tularemia: History, Epidemiology, Pathogen Physiology, and Clinical Manifestations , 2007, Annals of the New York Academy of Sciences.

[20]  D. Metzger,et al.  Mucosal Immunopathogenesis of Francisella tularensis , 2007, Annals of the New York Academy of Sciences.

[21]  J. Belisle,et al.  Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu41 , 2007, The Journal of Immunology.

[22]  J. Frelinger,et al.  Francisella tularensis-Infected Macrophages Release Prostaglandin E2 that Blocks T Cell Proliferation and Promotes a Th2-Like Response1 , 2007, The Journal of Immunology.

[23]  C. García-Rodríguez,et al.  Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS. , 2006, International immunology.

[24]  D. Metzger,et al.  Intranasal Interleukin-12 Treatment for Protection against Respiratory Infection with the Francisella tularensis Live Vaccine Strain , 2005, Infection and Immunity.

[25]  B. Gibson,et al.  Novel Modification of Lipid A of Francisella tularensis , 2004, Infection and Immunity.

[26]  Tara L. Kieffer,et al.  In Vivo Clearance of an Intracellular Bacterium, Francisella tularensis LVS, Is Dependent on the p40 Subunit of Interleukin-12 (IL-12) but Not on IL-12 p70 , 2002, Infection and Immunity.

[27]  G. Köhler,et al.  Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. , 1997, Journal of immunology.

[28]  A. Sjöstedt,et al.  The requirement of tumour necrosis factor-α and interferon-γ for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum , 1996 .

[29]  J. Kelly,et al.  Administration of interleukin‐10 abolishes innate resistance to Listeria monocytogenes , 1996, European journal of immunology.

[30]  A. Fortier,et al.  Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells , 1994, Infection and immunity.

[31]  Possession, use, and transfer of select agents and toxins; biennial review. Final rule. , 2012, Federal register.

[32]  A. Sjöstedt,et al.  The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum. , 1996, Microbiology.